February 2022 - United States - Uber, Lyft - Rideshare companies continue to expand into the non-emergency medical transportation

For the past few years, rideshare companies Lyft and Uber have been moving into the non-emergency medical transportation (NEMT) business, offering their networks to healthcare organizations that need to schedule rides for patients.

NEMT is used as a way to help low-income patients and Medicaid recipients get to appointments they might otherwise miss because they lack access to transportation. The need for such services is significant: millions of people in the United States, mostly low income, miss doctors’ appointments each year because of transportation barriers, costing the health system billions of dollars. But while NEMT is often done through dedicated companies, rideshare groups are now interested in what’s estimated to be a $3 billion market.

Rideshare is a cheaper alternative for healthcare organizations, and some experts think it has the potential to fill gaps in what NEMT services are able to offer. But research so far hasn’t borne that out, and clinicians say they worry that Uber and Lyft drivers aren’t adequately trained to safely transport the types of passengers who typically use NEMT.

Both companies have expanded their partnerships with the healthcare sector over the past few years. Uber and Lyft now have their systems built into some electronic health record platforms, so doctors can schedule directly through a patient’s medical record. They also have specialized programs available in some cities, called Lyft Assisted and Uber Assist, where drivers provide light physical assistance walking riders door to door rather than just taking passengers curb to curb. While Lyft and Uber consider their assisted services to be separate from their NEMT programs, there’s some overlap: healthcare organizations partnering with Lyft for NEMT can schedule Lyft Assisted rides for patients, and Uber’s NEMT program pulls from the general driver pool, which includes Uber Assist drivers.

Read on: in English

Loading...